[go: up one dir, main page]

AU8700291A - Hcv-specific peptides, agents therefor and the use thereof - Google Patents

Hcv-specific peptides, agents therefor and the use thereof

Info

Publication number
AU8700291A
AU8700291A AU87002/91A AU8700291A AU8700291A AU 8700291 A AU8700291 A AU 8700291A AU 87002/91 A AU87002/91 A AU 87002/91A AU 8700291 A AU8700291 A AU 8700291A AU 8700291 A AU8700291 A AU 8700291A
Authority
AU
Australia
Prior art keywords
hcv
specific peptides
agents therefor
antibodies
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU87002/91A
Other versions
AU657497B2 (en
Inventor
Stefan Brust
Manfred Gerken
Udo Krupka
Werner Stuber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Dade Behring Marburg GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27435056&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU8700291(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE4034982A external-priority patent/DE4034982C2/en
Priority claimed from DE4112743A external-priority patent/DE4112743C2/en
Priority claimed from DE4120281A external-priority patent/DE4120281C2/en
Priority claimed from DE4121431A external-priority patent/DE4121431A1/en
Application filed by Dade Behring Marburg GmbH filed Critical Dade Behring Marburg GmbH
Publication of AU8700291A publication Critical patent/AU8700291A/en
Application granted granted Critical
Publication of AU657497B2 publication Critical patent/AU657497B2/en
Assigned to DADE BEHRING MARBURG GMBH reassignment DADE BEHRING MARBURG GMBH Request to Amend Deed and Register Assignors: BEHRINGWERKE AKTIENGESELLSCHAFT
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K16/118—
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

New peptides (I) which react specifically with antibodies to hepatitis C virus (HCV) have amino acid sequences corresp. to portions of the HCV C-100-3 construct (see WO8904669). DNA sequences coding for (I), and antibodies with specific affinity for (I), are also new.
AU87002/91A 1990-11-03 1991-11-01 HCV-specific peptides, agents therefor and the use thereof Expired AU657497B2 (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
DE4034982A DE4034982C2 (en) 1990-11-03 1990-11-03 Synthetic polypeptides for the determination of HCV antibodies and HCV antigens, agents therefor and their use in these detection methods
DE4034982 1990-11-03
DE4112743A DE4112743C2 (en) 1991-04-19 1991-04-19 Synthetic core peptides for the determination of HCV antibodies and HCV antigens, agents therefor and their use in these detection methods
DE4112743 1991-04-19
DE4120281A DE4120281C2 (en) 1991-06-19 1991-06-19 Immunochemical method for the simultaneous detection of several different antibody specificities, peptide mixtures and test therefor
DE4120281 1991-06-19
DE4121431 1991-06-28
DE4121431A DE4121431A1 (en) 1991-06-28 1991-06-28 SYNTHETIC CORE PEPTIDES FOR DETERMINING HCV ANTIBODIES AND HCV ANTIGENS, MEANS THEREFOR AND THEIR USE IN THESE DETECTION METHODS

Publications (2)

Publication Number Publication Date
AU8700291A true AU8700291A (en) 1992-05-07
AU657497B2 AU657497B2 (en) 1995-03-16

Family

ID=27435056

Family Applications (1)

Application Number Title Priority Date Filing Date
AU87002/91A Expired AU657497B2 (en) 1990-11-03 1991-11-01 HCV-specific peptides, agents therefor and the use thereof

Country Status (8)

Country Link
EP (2) EP0484787B1 (en)
JP (2) JP4097162B2 (en)
AT (2) ATE318309T1 (en)
AU (1) AU657497B2 (en)
CA (1) CA2054798C (en)
DE (2) DE59109221D1 (en)
DK (2) DK0770679T4 (en)
ES (2) ES2161682T3 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU652851B2 (en) * 1991-07-04 1994-09-08 Boehringer Mannheim Gmbh Hepatitis C virus from C-100-3 and env/core regions
AU662517B2 (en) * 1991-01-31 1995-09-07 Abbott Laboratories Monoclonal antibodies to putative HCV envelope region and methods for using same
AU679429B2 (en) * 1991-09-13 1997-07-03 Novartis Vaccines And Diagnostics, Inc. Immunoreactive hepatitis C virus polypeptide compositions

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5683864A (en) * 1987-11-18 1997-11-04 Chiron Corporation Combinations of hepatitis C virus (HCV) antigens for use in immunoassays for anti-HCV antibodies
US5712087A (en) * 1990-04-04 1998-01-27 Chiron Corporation Immunoassays for anti-HCV antibodies employing combinations of hepatitis C virus (HCV) antigens
US5910404A (en) 1990-12-14 1999-06-08 Innogenetics N.V. Synthetic antigens for the detection of antibodies to hepatitis C virus
ES2095852T3 (en) * 1990-12-14 1997-03-01 Innogenetics Nv SYNTHETIC ANTIGENS FOR THE DETECTION OF ANTIBODIES AGAINST THE HEPATITIS C VIRUS.
US6007982A (en) * 1990-12-14 1999-12-28 Innogenetics N.V. Synthetic antigens for the detection of antibodies to hepatitis C virus
GB9105871D0 (en) * 1991-03-20 1991-05-08 Inst Cientifico Tecnol Navarra Synthetic peptides
US5574132A (en) * 1991-04-05 1996-11-12 Biochem Immunosystems Inc. Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV)
WO1992022571A1 (en) * 1991-06-13 1992-12-23 Baxter Diagnostics Inc. Immunoassay for non-a non-b hepatitis
ES2188583T3 (en) 1991-06-24 2003-07-01 Chiron Corp POLYPEPTIDES FOR HEPATITIS C VIRUS (HCV).
AU2068992A (en) * 1991-08-02 1993-02-04 Akzo N.V. Non-a, non-b peptide
EP0610436B9 (en) * 1991-11-21 2003-03-26 Common Services Agency Hepatitis-c virus testing
WO1993011158A2 (en) * 1991-12-06 1993-06-10 Akzo Nobel N.V. Non-a, non-b peptides
DK0891982T3 (en) * 1992-03-06 2007-09-03 Innogenetics Nv HIV peptides
US6667387B1 (en) 1996-09-30 2003-12-23 N.V. Innogenetics S.A. HCV core peptides
US6709828B1 (en) 1992-03-06 2004-03-23 N.V. Innogenetics S.A. Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them
FR2690921B1 (en) 1992-05-06 1995-06-30 Bio Merieux SYNTHESIS POLYPEPTIDES BELONGING TO HEPATITIS C VIRUS (HCV) AND USED IN PARTICULAR FOR DETECTING THE SAME.
DE69334328D1 (en) * 1992-07-16 2010-06-10 Advanced Life Science Inst Inc Antigenic peptides to group hepatitis C virus, kit and method of grouping using this kit
DE4240980A1 (en) * 1992-08-07 1994-02-10 Boehringer Mannheim Gmbh HCV peptide antigens and method for the determination of HCV
WO1994024560A1 (en) * 1993-04-14 1994-10-27 International Murex Technologies Corporation Immunoassay
GB2282884A (en) * 1993-04-14 1995-04-19 Int Murex Tech Corp Immunoassay
JPH07135981A (en) * 1993-05-28 1995-05-30 Eisai Co Ltd Non-a, non-b hepatitis virus gene-derived dna and polypeptide constituting the same
CA2125467C (en) * 1993-07-06 2001-02-06 Heinz Dobeli Process for producing hydrophobic polypeptides, proteins or peptides
US5670310A (en) * 1994-07-29 1997-09-23 The United States Of America As Represented By The Department Of Health And Human Services Methods and compositions for differential diagnosis of acute and chronic hepatitis c virus infection
JP3665371B2 (en) * 1994-08-31 2005-06-29 株式会社先端生命科学研究所 Epitope chimera antigen peptide for hepatitis C virus infection or group determination, production method thereof, and infection or group determination method using the same
DE19540105C1 (en) * 1995-09-19 1997-02-20 United Biomedical Inc Compsn. contg. synthetic peptide(s) reactive with hepatitis C related antibodies
DE19637718A1 (en) 1996-04-01 1997-10-02 Boehringer Mannheim Gmbh Recombinant inactive core streptavidin mutants
GB9624750D0 (en) * 1996-11-28 1997-01-15 Univ London Capture assays
FR2760367B1 (en) * 1997-03-06 1999-04-30 Pasteur Merieux Serums Vacc VACCINE COMPOSITION FOR THE PREVENTION OR TREATMENT OF HEPATITIS C
WO1999058561A1 (en) * 1998-05-14 1999-11-18 Pasteur Merieux Serums & Vaccins Hepatitis c virus mimotopes
ES2248357T3 (en) * 2000-07-07 2006-03-16 Medmira Inc. HCV MOSAIC ANTIGEN COMPOSITION.
FR2987836A1 (en) * 2012-03-09 2013-09-13 Biomerieux Sa INTERFERENCE PEPTIDES AND METHOD FOR DETECTING MICROORGANISMS

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1049686C (en) * 1987-11-18 2000-02-23 希龙股份有限公司 Diagnosis and vaccines for non-A and non-B hepatitis viruses
US5191064A (en) * 1988-09-30 1993-03-02 The Research Foundation For Microbial Diseases (Osaka University) Non-a, non-b hepatitis virus antigen peptide
JP2656995B2 (en) * 1989-03-17 1997-09-24 カイロン コーポレイション NANBV diagnostics
CA2065287C (en) * 1989-09-15 1999-12-21 Tatsuo Miyamura New hcv isolates
CA2032907C (en) * 1989-12-22 2002-05-14 Richard R. Lesniewski Hepatitis c assay
KR940000755B1 (en) * 1990-02-16 1994-01-29 유나이티드 바이오메디칼 인코오포레이티드 Synthetic peptides that are particularly suitable for detecting antibodies to HCV, diagnosing HCV infections and their prevention as vaccines
AU635124B2 (en) * 1990-04-16 1993-03-11 United Biomedical Inc. Synthetic peptides specific for the detection of antibodies to HCV, diagnosis of HCV infection and prevention thereof as vaccines
CA2047792C (en) * 1990-07-26 2002-07-02 Chang Y. Wang Synthetic peptides specific for the detection of antibodies to hcv, diagnosis of hcv infection and prevention thereof as vaccines
ES2095852T3 (en) * 1990-12-14 1997-03-01 Innogenetics Nv SYNTHETIC ANTIGENS FOR THE DETECTION OF ANTIBODIES AGAINST THE HEPATITIS C VIRUS.

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU662517B2 (en) * 1991-01-31 1995-09-07 Abbott Laboratories Monoclonal antibodies to putative HCV envelope region and methods for using same
AU652851B2 (en) * 1991-07-04 1994-09-08 Boehringer Mannheim Gmbh Hepatitis C virus from C-100-3 and env/core regions
AU679429B2 (en) * 1991-09-13 1997-07-03 Novartis Vaccines And Diagnostics, Inc. Immunoreactive hepatitis C virus polypeptide compositions

Also Published As

Publication number Publication date
EP0770679A2 (en) 1997-05-02
DE59109271D1 (en) 2006-04-27
ES2161682T3 (en) 2001-12-16
ES2255068T3 (en) 2006-06-16
DK0484787T3 (en) 2002-02-04
JPH04330098A (en) 1992-11-18
AU657497B2 (en) 1995-03-16
CA2054798A1 (en) 1992-05-04
ATE206717T1 (en) 2001-10-15
EP0770679B1 (en) 2006-02-22
JP2003192697A (en) 2003-07-09
ATE318309T1 (en) 2006-03-15
CA2054798C (en) 2009-08-18
DK0770679T4 (en) 2010-05-10
EP0770679B2 (en) 2009-12-30
DK0770679T3 (en) 2006-04-03
EP0770679A3 (en) 1997-05-21
ES2255068T5 (en) 2010-08-03
EP0484787B1 (en) 2001-10-10
EP0484787A2 (en) 1992-05-13
JP4097191B2 (en) 2008-06-11
EP0484787A3 (en) 1992-08-12
JP4097162B2 (en) 2008-06-11
DE59109221D1 (en) 2001-11-15

Similar Documents

Publication Publication Date Title
AU8700291A (en) Hcv-specific peptides, agents therefor and the use thereof
WO1993000365A3 (en) Hepatitis c virus (hcv) polypeptides
DK0637342T3 (en) Method for typing HCV isolates
PT725824E (en) HEPATITIS C VIRUS IMMUNODOMINANT HUMAN T-CELL EPITOPS
SG50563A1 (en) New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents
GR3006171T3 (en)
GR3023664T3 (en) Synthetic antigens for the detection of antibodies to hepatitis C virus.
CA2032381A1 (en) Viral agent
ATE423204T1 (en) PRODUCTION AND PURIFICATION OF HEPATITIS C VIRUS-LIKE PARTICLES
HUT73384A (en) Methods of typing hepatitis c virus and reagents for use therein
NZ518999A (en) Vaccine compositions
AU2197392A (en) Hepatitis C virus from C-100-3 and env/core regions
ATE310817T1 (en) METHODS AND COMPOSITIONS FOR CONTROLLING THE TRANSLATION OF HCV PROTEINS
ZA9811316B (en) Novel hepatitis C virus NS5B protein
WO2001021807A8 (en) Hepatitis c virus envelope two protein (e2) which lacks all or part of the hypervariable region one (hvr1), corresponding nucleic acids, chimeric viruses and uses thereof
EP1501936A4 (en) Cytokine protein family
AU6292694A (en) Novel polypeptide, dna coding for said polypeptide, recombinant vector containing said dna, recombinant virus prepared using said vector, and use thereof
EP0516859A4 (en)
NZ504633A (en) A dna molecule encoding a mutant prepro-neuropeptide y, a mutant signal peptide, and uses thereof
SE9402253D0 (en) Process
FI952778L (en) Hepatitis C virus (HCV) 3-nonstructural peptides, antibodies thereto, and methods for detecting HCV
KR950000882A (en) Nucleotide and Amino Acid Sequences of the Hypervariable Region of Korean Hepatitis C Virus
KR950000881A (en) Nucleotide Sequences and Amino Acid Sequences Inferred from the New Korean Hepatitis C Virus CDD
AU4405689A (en) New limphokines, dna sequences coding for said limphokines and pharmaceutical compositions containing said limphokines
SG145521A1 (en) Synthetic antigens for the detection of antibodies to hepatitis c virus